Constitutive IP3 signaling underlies the sensitivity of B-cell cancers to the Bcl-2/IP3 receptor disruptor BIRD-2-Reference-Cited by-同舟云学术

Constitutive IP3 signaling underlies the sensitivity of B-cell cancers to the Bcl-2/IP3 receptor disruptor BIRD-2

Published:2018-06-13 Issue:3 Volume:26 Page:531-547
ISSN:1350-9047
Container-title:Cell Death & Differentiation
language:en
Short-container-title:Cell Death Differ

Author:

Bittremieux Mart,La Rovere Rita M.,Akl Haidar,Martines Claudio,Welkenhuyzen Kirsten,Dubron Kathia,Baes Myriam,Janssens Ann,Vandenberghe Peter,Laurenti Luca,Rietdorf Katja,Morciano Giampaolo,Pinton Paolo^ORCID,Mikoshiba Katsuhiko,Bootman Martin D.^ORCID,Efremov Dimitar G.,De Smedt Humbert,Parys Jan B.^ORCID,Bultynck Geert^ORCID

Funder

Fonds Wetenschappelijk Onderzoek

Bijzonder Onderzoeksfonds

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/s41418-018-0142-3.pdf

Reference50 articles.

1. Placzek WJ, Wei J, Kitada S, Zhai D, Reed JC, Pellecchia M. A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy. Cell Death Dis. 2010;1:e40.

2. Brunelle JK, Letai A. Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci. 2009;122:437–41.